Identification of a novel distal enhancer in human adiponectin gene

Journal of Endocrinology

Volumn 200, Issue 1, 2009, Pages 107-116

  Segawa, Katsumori ^a,b,c   Matsuda, Morihiro ^a,d,e   Fukuhara, Atsunori ^a   Morita, Kentaro ^a   Okuno, Yosuke ^a   Komuro, Ryutaro ^a   Shimomura, Iichiro ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

^d National Hospital Organization   (Japan)

^e NATIONAL HOSPITAL ORGANIZATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; GENOMIC DNA; LUCIFERASE; MESSENGER RNA; SMALL INTERFERING RNA;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CELL TYPE; CONTROLLED STUDY; DELETION MUTANT; DNA FLANKING REGION; ENHANCER REGION; GENE ACTIVITY; GENE CONSTRUCT; GENETIC CONSERVATION; GENOME ANALYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE BINDING SITE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN RNA BINDING; SPECIES DIFFERENCE; STRUCTURE ACTIVITY RELATION; TRANSCRIPTION INITIATION; TRANSCRIPTION INITIATION SITE;

3T3 CELLS; ADIPOCYTES; ADIPONECTIN; ANIMALS; BASE SEQUENCE; BINDING SITES; CCAAT-ENHANCER-BINDING PROTEINS; ENHANCER ELEMENTS, GENETIC; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; MICE; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; SEQUENCE ALIGNMENT; TRANSCRIPTION, GENETIC;

EID: 67449110137     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-08-0376     Document Type: Article

References (37)

1. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K et al. 1999 Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochemical and Biophysical Research Communications 257 79-83.
2. Berg AH, Combs TP & Scherer PE 2002 ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends in Endocrinology and Metabolism 13 84-89.
3. Dixon TM, Daniel KW, Farmer SR & Collins S 2001 CCAAT/ enhancer-binding protein a is required for transcription of the β 3-adrenergic receptor gene during adipogenesis. Journal of Biological Chemistry 276 722-728.
4. Elberg G, Gimble JM & Tsai SY 2000 Modulation of the murine peroxisome proliferator-activated receptor gamma 2 promoter activity by CCAAT/enhancer-binding proteins. Journal of Biological Chemistry 275 27815-27822.
5. Hartman HB, Hu X, Tyler KX, Dalal CK & Lazar MA 2002 Mechanisms regulating adipocyte expression of resistin. Journal of Biological Chemistry 277 19754-19761.
6. Hotamisligil GS & Spiegelman BM 1994 Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 43 1271-1278.
7. Hu E, Liang P & Spiegelman BM 1996 AdipoQ is a novel adipose-specific gene dysregulated in obesity. Journal of Biological Chemistry 271 10697-10703.
8. Hwang CS, Mandrup S, MacDougald OA, Geiman DE & Lane MD 1996 Transcriptional activation of the mouse obese (ob) gene by CCAAT/ enhancer binding protein alpha. PNAS 93 873-877.
9. Iwaki M, Matsuda M, Maeda N, Funahashi T, Matsuzawa Y, Makishima M & Shimomura I 2003 Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 52 1655-1663.
10. Kaneko E, Matsuda M, Yamada Y, Tachibana Y, Shimomura I & Makishima M 2003 Induction of intestinal ATP-binding cassette transporters by a phytosterol-derived liver X receptor agonist. Journal of Biological Chemistry 278 36091-36098.
11. Kim HB, Kong M, Kim TM, Suh YH, Kim WH, Lim JH, Song JH & Jung MH 2006 NFATc4 and ATF3 negatively regulate adiponectin gene expression in 3T3-L1 adipocytes. Diabetes 55 1342-1352.
12. Kovacs KA, Steinmann M, Magistretti PJ, Halfon O & Cardinaux JR 2003 CCAAT/enhancer-binding protein family members recruit the coactivator CREB-binding protein and trigger its phosphorylation. Journal of Biological Chemistry 278 36959-36965.
13. Kubota N, Yano W, Kubota T, Yamauchi T, Itoh S, Kumagai H, Kozono H, Takamoto I, Okamoto S, Shiuchi T et al. 2007 Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. Cell Metabolism 6 55-68.
14. Lee EC, Yu D, Martinez de Velasco J, Tessarollo L, Swing DA, Court DL, Jenkins NA & Copeland NG 2001 A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics 73 56-65.
15. Lee TI, Johnstone SE & Young RA 2006 Chromatin immunoprecipitation and microarray-based analysis of protein location. Nature Protocols 1 729-748.
16. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y & Matsubara K 1996 cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (adipose most abundant gene transcript 1). Biochemical and Biophysical Research Communications 221 286-289.
17. Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K, Nagaretani H, Matsuda M, Komuro R, Ouchi N et al. 2001 PPAR gamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50 2094-2099.
18. Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, Furuyama N, Kondo H, Takahashi M, Arita Y et al. 2002 Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nature Medicine 8 731-737.
19. Mandrup S & Lane MD 1997 Regulating adipogenesis. Journal of Biological Chemistry 272 5367-5370.
20. Mason MM, He Y, Chen H, Quon MJ & Reitman M 1998 Regulation of leptin promoter function by Sp1, C/EBP, and a novel factor. Endocrinology 139 1013-1022.
21. Matsuzawa Y, Funahashi T & Nakamura T 1999 Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances. Annals of the New York Academy of Sciences 892 146-154.
22. Park SK, Oh SY, Lee MY, Yoon S, Kim KS & Kim JW 2004 CCAAT/enhancer binding protein and nuclear factor-Y regulate adiponectin gene expression in adipose tissue. Diabetes 53 2757-2766.
23. Qiao L, Maclean PS, Schaack J, Orlicky DJ, Darimont C, Pagliassotti M, Friedman JE & Shao J 2005 C/EBPalpha regulates human adiponectin gene transcription through an intronic enhancer. Diabetes 54 1744-1754.
24. Qiao L, Schaack J & Shao J 2006 Suppression of adiponectin gene expression by histone deacetylase inhibitor valproic acid. Endocrinology 147 865-874.
25. Ramji DP & Foka P 2002 CCAAT/enhancer-binding proteins: structure, function and regulation. Biochemical Journal 365 561-575.
26. Rosen ED & Spiegelman BM 2001 PPARgamma: a nuclear regulator of metabolism, differentiation, and cell growth. Journal of Biological Chemistry 276 37731-37734.
27. Scherer PE, Williams S, Fogliano M, Baldini G & Lodish HF 1995 A novel serum protein similar to C1q, produced exclusively in adipocytes. Journal of Biological Chemistry 270 26746-26749.
28. Segawa K, Fukuhara A, Hosogai N, Morita K, Okuno Y, Tanaka M, Nakagawa Y, Kihara S, Funahashi T, Komuro R et al. 2006 Visfatin in adipocytes is upregulated by hypoxia through HIF1alpha-dependent mechanism. Biochemical and Biophysical Research Communications 349 875-882.
29. Seo JB, Moon HM, Noh MJ, Lee YS, Jeong HW, Yoo EJ, Kim WS, Park J, Youn BS, Kim JW et al. 2004 Adipocyte determination- and differentiation-dependent factor 1/sterol regulatory element-binding protein 1c regulates mouse adiponectin expression. Journal of Biological Chemistry 279 22108-22117.
30. Shibata R, Sato K, Pimentel DR, Takemura Y, Kihara S, Ohashi K, Funahashi T, Ouchi N & Walsh K 2005 Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nature Medicine 11 1096-1103.
31. Shimomura I, Funahashi T, Takahashi M, Maeda K, Kotani K, Nakamura T, Yamashita S, Miura M, Fukuda Y, Takemura K et al. 1996 Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nature Medicine 2 800-803.
32. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS & Lazar MA 2001 The hormone resistin links obesity to diabetes. Nature 409 307-312.
33. Takemura Y, Ouchi N, Shibata R, Aprahamian T, Kirber MT, Summer RS, Kihara S & Walsh K 2007 Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies. Journal of Clinical Investigation 117 375-386.
34. Tuncman G, Erbay E, Hom X, De Vivo I, Campos H, Rimm EB & Hotamisligil GS 2006 A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease. PNAS 103 6970-6975.
35. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N et al. 2001 The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nature Medicine 7 941-946.
36. Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, Kotani K, Quadro L & Kahn BB 2005 Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 436 356-362.
37. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L & Friedman JM 1994 Positional cloning of the mouse obese gene and its human homologue. Nature 372 425-432.